Use of nanotechnology for infectious disease diagnostics: application in drug resistant tuberculosis

BMC Infect Dis. 2019 Jul 12;19(1):618. doi: 10.1186/s12879-019-4259-x.

Abstract

Background: The increased transmission of multidrug-resistant (MDR) tuberculosis (TB) poses a challenge to tuberculosis prevention and control in Sri Lanka. Isoniazid (INH) is a key element of the first line anti tuberculosis treatment regimen. Resistance to INH may lead to development of MDR TB. Therefore, early detection of INH resistance is important to curb spread of resistance. Due to the limited availability of rapid molecular methods for detection of drug resistance in Sri Lanka, this study was aimed at developing a simple and rapid gold nanoparticle (AuNP) based lateral flow strip for the simultaneous detection of the most common INH resistance mutation (katG S315 T, 78.6%) and Mycobacterium tuberculosis (MTb).

Methods: Lateral flow strip was designed on an inert plastic backing layer containing a sample pad, nitrocellulose membrane and an absorption pad. Biotin labeled 4 capture probes which separately conjugated with streptavidin were immobilized on the nitrocellulose. The test sample was prepared by multiplex PCR using primers to amplify codon 315 region of the katG gene and MTb specific IS6110 region. The two detection probes complementary to the 5' end of each amplified fragment was conjugated with gold nanoparticles (20 nm) and coupled with the above amplified PCR products were applied on the sample pad. The hybridization of the amplified target regions to the respective capture probes takes place when the sample moves towards the absorption pad. Positive hybridization is indicated by red colour lines.

Results: The three immobilized capture probes on the strip (for the detection of TB, katG wild type and mutation) were 100 and 96.6% specific and 100 and 92.1% sensitive respectively.

Conclusion: The AuNP based lateral flow assay was capable of differentiating the specific mutation and the wild type along with MTb identification within 3 h.

Keywords: Gold nanoparticles; Isoniazid; MDR TB; Mycobacterium tuberculosis.

MeSH terms

  • Antitubercular Agents / therapeutic use
  • Bacterial Proteins / genetics
  • Catalase / genetics
  • Communicable Diseases / diagnosis*
  • Communicable Diseases / drug therapy
  • DNA, Bacterial / isolation & purification
  • DNA, Bacterial / metabolism
  • Gold / chemistry
  • Humans
  • Isoniazid / therapeutic use
  • Limit of Detection
  • Metal Nanoparticles / chemistry
  • Multiplex Polymerase Chain Reaction
  • Mycobacterium tuberculosis / genetics
  • Mycobacterium tuberculosis / isolation & purification
  • Nanotechnology / methods*
  • Sri Lanka
  • Tuberculosis, Multidrug-Resistant / diagnosis*
  • Tuberculosis, Multidrug-Resistant / drug therapy

Substances

  • Antitubercular Agents
  • Bacterial Proteins
  • DNA, Bacterial
  • Gold
  • Catalase
  • katG protein, Mycobacterium tuberculosis
  • Isoniazid